Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc. - Common Stock (NQ:POAI)

1.450 -0.080 (-5.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,078,733
Open 1.430
Bid (Size) 1.380 (210)
Ask (Size) 1.430 (13)
Prev. Close 1.530
Today's Range 1.260 - 1.510
52wk Range 0.5500 - 3.060
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety

Performance

YTD
+57.6%
+57.6%
1 Month
+9.8%
+9.8%
3 Month
+68.8%
+68.8%
6 Month
+91.4%
+91.4%
1 Year
-47.8%
-47.8%

More News

Read More
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
Via Chartmill
Discover the most active stocks in Tuesday's session.
Via Chartmill
(POAI) - Analyzing Predictive Oncology's Short Interest
Via Benzinga
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
What's Going On With Predictive Oncology Shares Tuesday?
Via Benzinga
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
From Predictive Oncology Inc.
Via GlobeNewswire
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Closes Registered Direct Offering
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Predictive Oncology Inc.
Via GlobeNewswire
What's Going On With Predictive Oncology Shares Tuesday?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
From Predictive Oncology Inc.
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
From Renovaro Inc
Via GlobeNewswire

Frequently Asked Questions

Is Predictive Oncology Inc. - Common Stock publicly traded?
Yes, Predictive Oncology Inc. - Common Stock is publicly traded.
What exchange does Predictive Oncology Inc. - Common Stock trade on?
Predictive Oncology Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Predictive Oncology Inc. - Common Stock?
The ticker symbol for Predictive Oncology Inc. - Common Stock is POAI on the Nasdaq Stock Market
What is the current price of Predictive Oncology Inc. - Common Stock?
The current price of Predictive Oncology Inc. - Common Stock is 1.450
When was Predictive Oncology Inc. - Common Stock last traded?
The last trade of Predictive Oncology Inc. - Common Stock was at 03/28/25 04:00 PM ET
What is the market capitalization of Predictive Oncology Inc. - Common Stock?
The market capitalization of Predictive Oncology Inc. - Common Stock is 5.89M
How many shares of Predictive Oncology Inc. - Common Stock are outstanding?
Predictive Oncology Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.